The clinical spectrum of primary Sjögren’s syndrome: beyond exocrine glands

Submitted: 20 June 2017
Accepted: 28 July 2017
Published: 21 September 2017
Abstract Views: 2701
PDF: 1361
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Although primary Sjögren’s syndrome (pSS) is a mild indolent chronic disease mainly characterized by mucosal dryness in the majority of cases, a consistent subgroup of patients display extra-glandular manifestations. Virtually any organs and systems can be affected, leading to a more serious disease prognosis. Therefore, the prompt identification of patients at higher risk of extra-glandular manifestations is necessary to start a thorough follow up and an aggressive treatment. The aim of this review article is to provide an overview of epidemiological, clinical and serological features of extra-glandular manifestations in pSS as well as current knowledge about putative biomarkers useful in clinical practice.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

How to Cite

Leone, M., Alunno, A., Cafaro, G., Valentini, V., Marcucci, E., Bartoloni, E., & Gerli, R. (2017). The clinical spectrum of primary Sjögren’s syndrome: beyond exocrine glands. Reumatismo, 69(3), 93–100. https://doi.org/10.4081/reumatismo.2017.1032